Dekker, Douwe <br/><br/>
The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Feb 2011 
 - 458-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4636 
<br/><br/><label>Standard No.: </label>10.1161/ATVBAHA.110.211789  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcholine--pharmacology<br/>Aged<br/>Atazanavir Sulfate<br/>Bilirubin--blood<br/>Cross-Over Studies<br/>Diabetes Mellitus, Type 2--metabolism<br/>Double-Blind Method<br/>Endothelium, Vascular--drug effects<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Nitroglycerin--pharmacology<br/>Oligopeptides--pharmacology<br/>Oxidative Stress--drug effects<br/>Pyridines--pharmacology<br/>Vasodilation--drug effects<br/>Vasodilator Agents--pharmacology<br/>von Willebrand Factor--metabolism